---
title: "SIGAL CHARLES ELLIOTT — Ownership Dossier"
canonical: https://whiteintel.dev/entity/8c992bf0-ea35-5f9a-b559-2323ef359b07
json: https://whiteintel.dev/api/public/dossier/8c992bf0-ea35-5f9a-b559-2323ef359b07
identifier: sec:0001661908
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# SIGAL CHARLES ELLIOTT

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001661908`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/8c992bf0-ea35-5f9a-b559-2323ef359b07  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/8c992bf0-ea35-5f9a-b559-2323ef359b07  

## Ownership & control

### Holdings / subsidiaries

- **ALNYLAM PHARMACEUTICALS, INC.** (director) — https://whiteintel.dev/entity/4b418581-d371-5444-94c4-d4cbdecc07b2
- **Vir Biotechnology, Inc.** (director) — https://whiteintel.dev/entity/ca406276-b865-57f4-af53-1e507124bc69
- **Adaptimmune Therapeutics PLC** (director) — https://whiteintel.dev/entity/ef384144-24c7-5e0d-b0b8-7ca4452a0960
- **SURFACE ONCOLOGY, INC.** (director) — https://whiteintel.dev/entity/5dbea9e7-99ee-564a-8db1-1e330fa1db13

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **SIGAL CHARLES ELLIOTT**. Human view: https://whiteintel.dev/entity/8c992bf0-ea35-5f9a-b559-2323ef359b07 · Structured JSON: https://whiteintel.dev/api/public/dossier/8c992bf0-ea35-5f9a-b559-2323ef359b07._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._